Aliomrani Mehdi, Mesripour Azadeh, Mehrjardi Abolfazl Saleki
Isfahan University of Medical Sciences, School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology and Toxicology, Isfahan, Iran
Isfahan University of Medical Sciences, School of Pharmacy and Pharmaceutical Sciences, Isfahan Pharmaceutical Sciences Research Center, Isfahan, Iran
Turk J Pharm Sci. 2022 Apr 29;19(2):196-201. doi: 10.4274/tjps.galenos.2021.27217.
Cyclosporine A (CYA), is an immunosuppressant drug used to prevent graft rejection, but it may initiate neuropsychological problems such as depression. The aim was to evaluate the antidepressant-like effects of creatine (Crt), a mediator of oxidative phosphorylation, and alpha-lipoic acid (ALA), a cofactor for the mitochondrial respiratory chain following CYA administration.
Female mice (27 ± 2 g) were used, immobility time during the forced swimming test (FST) was measured, and hippocampal brain-derived neurotrophic factor (BDNF) level was evaluated. CYA 20 mg/kg, ALA 40 mg/kg, fluoxetine 20 mg/kg, and Crt 10 mg/kg (oral) were administered for 6 consecutive days, and the tests were performed on day 7.
ALA, but not Crt, treatment alone decreased immobility in the FST (., decreases depression-like behavior). CYA administration increased immobility in the FST (175.1 ± 13.16 s, vs. vehicle 130.9 ± 13.5 s, = 0.0364), and this depression-like behavior was prevented by co-administrating, ALA (100 ± 15.9 s, = 0.020) or Crt (93.5 ± 16.6, = 0.009) and the positive control, fluoxetine. Notably, there was a synergistic effect of Crt-ALA co-administration since CYA-induced immobility was lower in this group than in the groups pretreated with Crt or ALA. These behavioral changes were observed without treatment effects on locomotor activity in an open field. CYA treatment increased hippocampal BDNF protein levels prevented by co-administration of ALA (with or without Crt) or fluoxetine.
CYA-induced depression-like behavior might be related to hippocampal mitochondrial dysfunction as ALA and Crt prevented the development of this behavioral phenotype. ALA, similar to fluoxetine, prevented BDNF alteration and its possible neurological changes.
环孢素A(CYA)是一种用于预防移植排斥的免疫抑制药物,但它可能引发诸如抑郁等神经心理问题。本研究旨在评估肌酸(Crt)(一种氧化磷酸化的介质)和α-硫辛酸(ALA)(线粒体呼吸链的一种辅助因子)在给予CYA后是否具有抗抑郁样作用。
使用雌性小鼠(27±2g),测量强迫游泳试验(FST)中的不动时间,并评估海马脑源性神经营养因子(BDNF)水平。连续6天给予20mg/kg的CYA、40mg/kg的ALA、20mg/kg的氟西汀和10mg/kg(口服)的Crt,在第7天进行测试。
单独给予ALA(而非Crt)可减少FST中的不动时间(即减少抑郁样行为)。给予CYA会增加FST中的不动时间(175.1±13.16秒,而给予赋形剂时为130.9±13.5秒,P = 0.0364), 联合给予ALA(100±15.9秒, P = 0.020)或Crt(93.5±16.6秒, P = 0.009)以及阳性对照氟西汀可预防这种抑郁样行为。值得注意的是,Crt-ALA联合给药具有协同作用,因为该组中CYA诱导的不动时间低于用Crt或ALA预处理的组。在旷场试验中观察到这些行为变化,且对运动活动无治疗影响。CYA治疗可增加海马BDNF蛋白水平,联合给予ALA(有或无Crt)或氟西汀可预防这种增加。
CYA诱导的抑郁样行为可能与海马线粒体功能障碍有关,因为ALA和Crt可预防这种行为表型的发展。ALA与氟西汀类似,可预防BDNF改变及其可能的神经学变化。